JP Morgan Chase
CMND icon

JP Morgan Chase’s Clearmind Medicine CMND Stock Holding History

JP Morgan Chase’s Portfolio CMND Stock Details CMND Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-1
Closed -$9 – 7586
2025
Q4 		$9 Buy
+1
New +$199 ﹤0.01% 7337
2025
Q3 		– Sell
-9
Closed -$3.12K – 7433
2025
Q2 		$3.12K Buy
+9
New +$3.46K ﹤0.01% 6472

Other funds holding CMND

XT
XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return
HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
AI
AdvisorShares Investments Bethesda, Maryland $828M AUM 37.72% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

JP Morgan Chase's CMND Position: Q1 2026 in Review

JP Morgan Chase sold out of Clearmind Medicine (CMND) in Q1 2026, closing a stake of 1 share — an estimated $9 sold.

JP Morgan Chase first reported a position in CMND in Q2 2025 and held it in 2 quarters. The position peaked at $3.12K in Q2 2025. 4 funds tracked by Wall St. Rank hold CMND as of Q1 2026.

  • JP Morgan Chase reported no remaining Clearmind Medicine position as of Q1 2026 after selling out during the quarter.
  • JP Morgan Chase sold 1 Clearmind Medicine share in Q1 2026, an estimated $9.
  • JP Morgan Chase first reported a position in Clearmind Medicine in Q2 2025 and held it in 2 quarters.
  • JP Morgan Chase's Clearmind Medicine position peaked at $3.12K in Q2 2025.
  • 4 funds tracked by Wall St. Rank held Clearmind Medicine as of Q1 2026.

Based on JP Morgan Chase's 13F filing for Q1 2026, filed 13 May 2026.